CN106138502A - 一种治疗细菌性角膜炎的中西复方眼药水及制备方法 - Google Patents
一种治疗细菌性角膜炎的中西复方眼药水及制备方法 Download PDFInfo
- Publication number
- CN106138502A CN106138502A CN201610703228.6A CN201610703228A CN106138502A CN 106138502 A CN106138502 A CN 106138502A CN 201610703228 A CN201610703228 A CN 201610703228A CN 106138502 A CN106138502 A CN 106138502A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- collyrium
- western
- leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010023332 keratitis Diseases 0.000 title claims abstract description 33
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 30
- 150000001875 compounds Chemical class 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 66
- 239000000203 mixture Substances 0.000 claims abstract description 36
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 18
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 18
- 241000593559 Bullacta exarata Species 0.000 claims abstract description 17
- 241000522649 Zornia Species 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960004484 carbachol Drugs 0.000 claims abstract description 16
- 229960001180 norfloxacin Drugs 0.000 claims abstract description 16
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960004114 olopatadine Drugs 0.000 claims abstract description 16
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 claims abstract description 16
- 239000004615 ingredient Substances 0.000 claims abstract description 11
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- 238000005516 engineering process Methods 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 239000004570 mortar (masonry) Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 238000005202 decontamination Methods 0.000 claims description 5
- 230000003588 decontaminative effect Effects 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 210000004907 gland Anatomy 0.000 claims description 3
- 238000007731 hot pressing Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002105 nanoparticle Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 241000448458 Juniperus procumbens Species 0.000 claims 3
- 238000004821 distillation Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000004438 eyesight Effects 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 13
- 206010010726 Conjunctival oedema Diseases 0.000 abstract description 9
- 231100000614 poison Toxicity 0.000 abstract description 9
- 239000003440 toxic substance Substances 0.000 abstract description 9
- 241000475481 Nebula Species 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 8
- 230000001225 therapeutic effect Effects 0.000 abstract description 8
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 238000002560 therapeutic procedure Methods 0.000 abstract description 6
- 230000003115 biocidal effect Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 4
- 229940000425 combination drug Drugs 0.000 abstract description 3
- 230000007721 medicinal effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 210000001508 eye Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 8
- 208000025865 Ulcer Diseases 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 231100000397 ulcer Toxicity 0.000 description 8
- 208000001848 dysentery Diseases 0.000 description 7
- 206010034960 Photophobia Diseases 0.000 description 6
- 210000004087 cornea Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000000744 eyelid Anatomy 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010015958 Eye pain Diseases 0.000 description 4
- 240000000231 Ficus thonningii Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000909851 Epiphora Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 206010064996 Ulcerative keratitis Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 210000002159 anterior chamber Anatomy 0.000 description 3
- 210000001742 aqueous humor Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000795 conjunctiva Anatomy 0.000 description 3
- 201000007717 corneal ulcer Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010067268 Post procedural infection Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 206010005159 blepharospasm Diseases 0.000 description 2
- 230000000744 blepharospasm Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000003760 hair shine Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000002618 waking effect Effects 0.000 description 2
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000004130 Blepharoptosis Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011844 Dacryocystitis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 206010017012 Foreign body in eye Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 201000005471 chronic dacryocystitis Diseases 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000020992 contracted pupil Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 201000001891 corneal deposit Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 229960003923 gatifloxacin Drugs 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗细菌性角膜炎的中西复方眼药水及制备方法,属医药技术领域;本发明眼药水成分的原料组成为:狗狗秧,吐铁,骨节草,蒟酱叶,当归,丁葵草,菥蓂子,檵花叶,地柏叶,苋实,榕树胶汁,竹叶蕉,大巢菜,奥洛他定,卡巴胆碱和诺氟沙星;本发明眼药水采用中西医药结合的治疗方法比一般单纯的用中药、西药的治疗效果更佳,以清热解毒、消炎杀菌、明目去翳、消肿止痛、补肝益肾为治疗原则,可以最大效率的提高中药成分与西药功效,提高药用效果,外用直接滴入眼睛内部就能够杀灭细菌、抗菌性强,直接到达病变部位,使用方便,吸收效果好,无不良及毒副作用,对细菌性角膜炎引发的视力降低、球结膜水肿等具有良好的治疗效果。
Description
所属技术领域
本发明涉及医药技术领域,尤其涉及一种治疗细菌性角膜炎的中西复方眼药水及制备方法。
背景技术
细菌性角膜炎是因细菌感染而引起的化脓性角膜炎,又称细菌性角膜溃疡。细菌性角膜炎多为外伤后感染或剔除角膜异物后感染所致,如葡萄球菌、细球菌、链球菌、假单胞菌等,过量使用抗生素和糖皮质激素,干眼症、慢性泪囊炎、糖尿病等也可造成角膜对细菌易感性增加。
细菌性角膜炎的临床表现为:
1、起病急,常在角膜外伤后24~48小时发病。
2、眼红、疼痛、畏光、流泪、视力降低、眼睑痉挛及分泌物增多等。
3、眼睑肿胀、球结膜水肿、睫状充血或混合充血。病变早期角膜上出现一个界线清楚的上皮溃疡,溃疡下有边界模糊、致密的灰黄色浸润灶,周围组织水肿,浸润灶迅速扩大,形成溃疡,角膜溃疡向深层发展,即将发生穿孔时,在溃疡基底可出现一薄层透明组织,向前膨出,称为后弹力膜膨出,当角膜穿孔时患者即感觉到剧烈的疼痛和“热泪”(房水)流出,穿孔后前房较重的角膜炎症或角膜溃疡,其毒素进入前房可刺激虹膜睫状体发炎,虹膜睫状体充血、水肿,血管的渗透性改变,细胞渗入房水内,轻者房水混浊,或有角膜后沉着物,重者有大量脓性渗出物,沉积于前房底部,称前房积脓性角膜溃疡,如不及时治疗可产生虹膜后粘连。
细菌性角膜炎的病情多较危重,如果得不到有效治疗,可发生角膜溃疡穿孔,甚至眼内感染,最终眼球萎缩,危害不容小觑。目前治疗细菌性角膜炎的药物主要为西药,比如急性期用高浓度的抗生素滴眼液频繁点眼有所缓解,但中国传统医学对这种病其实有较好的疗法,只是见效稍慢于西医,因此,结合西医疗法和中医疗法,研究出一种疗效确切见效又快的用于细菌性角膜炎的眼药水是很有价值的。
发明内容
本发明提供了一种治疗细菌性角膜炎的中西复方眼药水及制备方法,本发明眼药水采用中西医药结合的治疗方法比一般单纯的用中药、西药的治疗效果更佳,以清热解毒、消炎杀菌、明目去翳、消肿止痛、补肝益肾为治疗原则,可以最大效率的提高中药成分与西药功效,发挥互补和提升的作用,提高药用效果,外用直接滴入眼睛内部就能够杀灭细菌、抗菌性强,直接到达病变部位,使用方便,吸收效果好,无不良及毒副作用,对细菌性角膜炎引发的眼红、畏光流泪、视力降低、眼睑肿胀、球结膜水肿等具有良好的治疗效果;本发明眼药水针对性强、疗效显著、成本低,经临床验证,疗程短、治愈率高、标本兼治,是一种值得大量推广应用的眼药水。
为实现上述目的,本发明的技术方案实施如下:
一种治疗细菌性角膜炎的中西复方眼药水,所述眼药水由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:狗狗秧55~85份,吐铁52~82份,骨节草50~80份,蒟酱叶48~78份,当归45~75份,丁葵草40~70份,菥蓂子37~67份,檵花叶35~65份,地柏叶33~63份,苋实30~60份,榕树胶汁28~58份,竹叶蕉26~56份,大巢菜25~55份;制成所述西药成分的原料组成及重量份数为:奥洛他定0.4~1.5份,卡巴胆碱0.3~1.4份,诺氟沙星0.1~1.2份。
所述眼药水由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:狗狗秧78份,吐铁75份,骨节草73份,蒟酱叶71份,当归68份,丁葵草63份,菥蓂子61份,檵花叶59份,地柏叶57份,苋实53份,榕树胶汁51份,竹叶蕉49份,大巢菜48份;制成所述西药成分的原料组成及重量份数为:奥洛他定1.2份,卡巴胆碱1.0份,诺氟沙星0.8份。
所述眼药水由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:狗狗秧71份,吐铁68份,骨节草66份,蒟酱叶64份,当归61份,丁葵草56份,菥蓂子54份,檵花叶51份,地柏叶50份,苋实46份,榕树胶汁44份,竹叶蕉42份,大巢菜41份;制成所述西药成分的原料组成及重量份数为:奥洛他定0.9份,卡巴胆碱0.8份,诺氟沙星0.5份。
所述眼药水由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:狗狗秧63份,吐铁59份,骨节草58份,蒟酱叶57份,当归53份,丁葵草48份,菥蓂子45份,檵花叶44份,地柏叶39份,苋实38份,榕树胶汁37份,竹叶蕉34份,大巢菜33份;制成所述西药成分的原料组成及重量份数为:奥洛他定0.6份,卡巴胆碱0.5份,诺氟沙星0.2份。
一种治疗细菌性角膜炎的中西复方眼药水的制备方法,包括以下工艺步骤:
(1)将狗狗秧、吐铁、菥蓂子和苋实放入容器中,加入相对混合物质量6~8倍量的蒸馏水浸泡2~3天后,加入3~4倍量的质量浓度为45%~55%乙醇,加热回流4小时,过滤,得提取液;将过滤后获得的药渣再加入相对药渣质量4~6倍量的蒸馏水,加热回流2小时;过滤,得提取液和药渣;合并两次提取液,冷却降温至25℃~30℃,过滤,得滤液,备用;
(2)将骨节草、蒟酱叶和大巢菜去除杂质,晒至半干,然后收回堆放,用麻布覆盖,焖两天后,除去麻布并晒至完全干透,捣碎,筛除灰屑,置于研钵内研末,得到过180目的细粉,备用;
(3)将当归和竹叶蕉拣去杂质,大小分档,切片,喷洒3倍量的盐与水的比例为1:50的盐水,搅拌均匀,稍闷润,置锅内用文火微炒至表面略变色,取出晾干,置于研钵内研末,得到过200目的细粉,备用;
(4)将丁葵草、檵花叶和地柏叶洗净,置于榨汁机内榨出汁液,冷藏4小时,过滤,除去杂质与沉淀物,经活性炭吸附进行脱色处理,得滤液,备用;
(5)将奥洛他定、卡巴胆碱和诺氟沙星放入超微粉碎机中粉碎成粒径小于0.1μm体积平均粒径的纳米级颗粒,备用;
(6)将步骤(1)、步骤(4)所得的滤液,步骤(2)、步骤(3)所得的细粉与步骤(5)所得的颗粒混合,加入榕树胶汁与10倍量的蒸馏水,并滴入碳酸氢钠溶液调节PH值至7.0,灌封压盖,在121℃热压下灭菌30分钟,制成10ml/瓶的眼药水,即为所述的治疗细菌性角膜炎的中西复方眼药水。
本发明所用中药的药效如下:
狗狗秧:清肝热,滋阴,利小便。用于肝阳上亢,头晕目眩,小便不利。《陆川本草》载:“利尿,解毒,消炎,治小儿皮肤泡疮,痢疾。”
吐铁:补肝肾,益精髓,明目,生津,润燥。《本草从新》载:“补肝肾,益精髓,明耳目。”
骨节草:疏风明目,活血舒筋。用于迎风流泪,翳膜遮睛,跌打损伤,肠风血痔。《闽东本草》载:“疏风,解肌,止血,退目翳,治目疾,迎风流泪,翳点遮睛,肠风痔漏,血痢,崩中。”
蒟酱叶:祛风燥湿,杀虫止痒。用于风寒咳嗽,胃痛,风毒脚气,子肿疥癞,湿疹脚癣,烫伤。《陆川本草》载:“驱虫,消肿,止痒,去腐生肌,治疳疔,溃疡,虫牙痛。”现代医学研究证实,蒟酱叶具有抗菌作用,其水提取物及酒精浸膏水提取物对金黄色葡萄球菌、白色葡萄球菌、大肠杆菌、变形杆菌、伤寒杆菌、枯草杆菌及某些真菌有明显抑菌作用。
当归:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,风湿痹痛,跌扑损伤,痈疽疮疡。《纲目》载:“治头痛,心腹诸痛,润肠胃,痈疽,排脓止痛,和血补血。”
丁葵草:清热,解毒,去瘀。用于感冒,高热抽搐,腹泻黄疸,痢疾,小儿疳积,喉痛目赤,疔疮肿毒,乳腺炎。《常用中草药手册》载:“清热解表,去瘀消肿,治感冒,眼结膜炎,肝炎,胃肠炎,痢疾,小儿疳积,毒蛇咬伤,跌打肿痛。”
菥蓂子:明目,祛风湿。用于目赤肿痛,障翳胬肉,迎风流泪,风湿痹痛。《本经》载:“主明目,目痛泪出,除痹,补五脏,益精光。”
檵花叶:清热止泻,活血止血。用于暑热泻痢,扭闪伤筋,创伤出血,目痛喉痛。《湖南药物志》载:“治中暑,喉痛,风热目痛。”现代医学研究证实,檵花叶具有抗菌作用,其提取物在试管内对链球菌、葡萄球菌、伤寒及大肠杆菌等均有抑菌作用。
地柏叶:清热解毒,止咳利咽,利湿消肿,止血止痛。用于流行性感冒,感冒咳嗽,扁桃体炎,腮腺炎,目赤肿痛,肠炎,痢疾,乳汁不下,疮肿疔毒,跌打损伤,烧烫伤,刀伤出血。《浙江民间常用草药》载:“清热解毒,平肝镇惊。”
苋实:清肝明目,通利二便。用于青盲翳障,视物昏暗,白浊血尿,二便不利。《本经》载:“主青盲,明目,除邪,利大小便,去寒热。”
榕树胶汁:明目去翳,解毒消肿。用于赤眼目翳,瘰疬唇疔,牛皮癣,赘疣。《南宁市药物志》载:“退目翳,消瘰疬。”
竹叶蕉:清热解毒,止咳定喘,消炎杀菌。用于肺结核,气管炎,支气管炎,哮喘,高热,小儿麻疹,合并肺炎,感冒发热,各种皮肤病。现代医学研究证实,竹叶蕉对痢疾杆菌、伤寒杆菌、绿脓杆菌、葡萄球菌等具有抑制作用。
大巢菜:清热利湿,和血祛瘀。用于黄疸浮肿,疟疾鼻衄,心悸梦遗,月经不调。《草木便方》载:“活血破血,止血生肌,治五黄疸肿,利脏热,截疟平胃,明耳目。”
本发明与现有技术相比,具有以下有益效果:
1、本发明眼药水采用中西医药结合的治疗方法比一般单纯的用中药、西药的治疗效果更佳,以清热解毒、消炎杀菌、明目去翳、消肿止痛、补肝益肾为治疗原则,可以最大效率的提高中药成分与西药功效,发挥互补和提升的作用,提高药用效果,外用直接滴入眼睛内部就能够杀灭细菌、抗菌性强,直接到达病变部位,使用方便,吸收效果好,无不良及毒副作用,对细菌性角膜炎引发的眼红、畏光流泪、视力降低、眼睑肿胀、球结膜水肿等具有良好的治疗效果。
2、本发明眼药水针对性强、疗效显著、成本低,经临床验证,疗程短、治愈率高、标本兼治,是一种值得大量推广应用的眼药水。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明眼药水成分的原料组成及重量为:狗狗秧84份,吐铁81份,骨节草79份,蒟酱叶77份,当归74份,丁葵草69份,菥蓂子66份,檵花叶64份,地柏叶62份,苋实59份,榕树胶汁57份,竹叶蕉55份,大巢菜54份,奥洛他定1.4份,卡巴胆碱1.3份,诺氟沙星1.1份。
本发明眼药水制备方法的工艺步骤为:
(1)将狗狗秧、吐铁、菥蓂子和苋实放入容器中,加入相对混合物质量6~8倍量的蒸馏水浸泡2~3天后,加入3~4倍量的质量浓度为45%~55%乙醇,加热回流4小时,过滤,得提取液;将过滤后获得的药渣再加入相对药渣质量4~6倍量的蒸馏水,加热回流2小时;过滤,得提取液和药渣;合并两次提取液,冷却降温至25℃~30℃,过滤,得滤液,备用;
(2)将骨节草、蒟酱叶和大巢菜去除杂质,晒至半干,然后收回堆放,用麻布覆盖,焖两天后,除去麻布并晒至完全干透,捣碎,筛除灰屑,置于研钵内研末,得到过180目的细粉,备用;
(3)将当归和竹叶蕉拣去杂质,大小分档,切片,喷洒3倍量的盐与水的比例为1:50的盐水,搅拌均匀,稍闷润,置锅内用文火微炒至表面略变色,取出晾干,置于研钵内研末,得到过200目的细粉,备用;
(4)将丁葵草、檵花叶和地柏叶洗净,置于榨汁机内榨出汁液,冷藏4小时,过滤,除去杂质与沉淀物,经活性炭吸附进行脱色处理,得滤液,备用;
(5)将奥洛他定、卡巴胆碱和诺氟沙星放入超微粉碎机中粉碎成粒径小于0.1μm体积平均粒径的纳米级颗粒,备用;
(6)将步骤(1)、步骤(4)所得的滤液,步骤(2)、步骤(3)所得的细粉与步骤(5)所得的颗粒混合,加入榕树胶汁与10倍量的蒸馏水,并滴入碳酸氢钠溶液调节PH值至7.0,灌封压盖,在121℃热压下灭菌30分钟,制成10ml/瓶的眼药水,即为所述的治疗细菌性角膜炎的中西复方眼药水。
用法用量:滴眼,用前充分摇匀,一日3次,一次1~2滴或遵医嘱,滴后闭目3~5分钟,以使眼药水内的药物充分地被吸收,孕妇、哺乳期妇女、未成年人及对本品过敏者慎用。
实施例2
本发明眼药水成分的原料组成及重量为:狗狗秧78份,吐铁75份,骨节草73份,蒟酱叶71份,当归68份,丁葵草63份,菥蓂子61份,檵花叶59份,地柏叶57份,苋实53份,榕树胶汁51份,竹叶蕉49份,大巢菜48份,奥洛他定1.2份,卡巴胆碱1.0份,诺氟沙星0.8份。
本实施例的眼药水制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明眼药水成分的原料组成及重量为:狗狗秧71份,吐铁68份,骨节草66份,蒟酱叶64份,当归61份,丁葵草56份,菥蓂子54份,檵花叶51份,地柏叶50份,苋实46份,榕树胶汁44份,竹叶蕉42份,大巢菜41份,奥洛他定0.9份,卡巴胆碱0.8份,诺氟沙星0.5份。
本实施例的眼药水制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明眼药水成分的原料组成及重量为:狗狗秧63份,吐铁59份,骨节草58份,蒟酱叶57份,当归53份,丁葵草48份,菥蓂子45份,檵花叶44份,地柏叶39份,苋实38份,榕树胶汁37份,竹叶蕉34份,大巢菜33份,奥洛他定0.6份,卡巴胆碱0.5份,诺氟沙星0.2份。
本实施例的眼药水制备方法工艺步骤及用法用量与实施例1相同。
眼部刺激性试验
1、选用健康白色家兔8只,雌雄各半,体重为4~5kg,将本发明眼药水0.1ml滴入家兔左眼结膜囊内,被动闭目3分钟,右眼作为对照滴入0.1ml生理盐水。
2、观察家兔12小时、24小时、36小时以及48小时内的眼睛局部变化。
3、结果:滴有本发明眼药水的家兔左眼角膜和虹膜正常,结膜未见水肿,未有充血,属无刺激性。
临床资料:
1、病例选择:
选择我院或外院确诊的细菌性角膜炎患者320例临床观察,患者随机分成两组,治疗组、对照组各项范围如下:
项目 | 治疗组 | 对照组 |
例数 | 160 | 160 |
男女比例 | 79∶81 | 41∶39 |
年龄范围 | 18~55岁 | 18~54岁 |
平均年龄 | 41岁 | 40岁 |
病程 | 10~45天 | 7~40天 |
两组病例的病程、症状轻重程度基本一致,无显著差异,具有可比性。
2、药物选择:
治疗组患者使用本发明眼药水,滴眼,用前充分摇匀,一日3次,一次1~2滴或遵医嘱,滴后闭目3~5分钟,以使眼药水内的药物充分地被吸收,孕妇、哺乳期妇女、未成年人及对本品过敏者慎用。
对照组使用加替沙星滴眼液,第1~2天,清醒状态下,2小时1次,1次1滴,每天8次;第3~7天,清醒状态下,每天4次,1次1滴。
3、疗效判定:
(1)治愈:眼红畏光、眼睑痉挛、视力下降、水肿充血等症状消失;眼睛恢复健康。
(2)有效:上述症状有所缓解。
(3)无效:上述症状无变化。
4、结果:
组 | 例数(例) | 治愈(例) | 有效(例) | 无效(例) | 治愈率 | 总有效率 |
治疗组 | 160 | 136 | 13 | 11 | 85% | 93.1% |
对照组 | 160 | 108 | 24 | 28 | 67.5% | 82.5% |
以上结果显示,治疗组治愈率和总有效率明显高于对照组。
典型病例举例:
1、钱××,男,18岁,学生。患者左眼被病菌感染患有角膜炎,眼睛很红,有疼痛感与异物感,视力模糊。使用本发明眼药水4天后,以上症状消失,眼睛恢复健康,随访至今未复发。
2、洪××,女,24岁,护士。患者患有细菌性角膜炎一月有余,曾使用过多种药物,并无明显好转。使用本发明眼药水2天,眼睛逐渐康复,继续使用本发明眼药水2天,眼睛痊愈,随访至今未复发。
3、邓××,女,22,办公室助理。患者眼睛发红,未予以重视,近期眼睛畏光,容易流泪,遂来我院检查,发现患者角膜处有溃疡,周围组织水肿,被确诊为细菌性角膜炎。使用本发明眼药水1天后,症状有所好转,继续使用2天,症状消失,没有复发。
4、丁××,男,33岁,财务主管。患者因外伤感染患有细菌性角膜炎,双眼眼睑痉挛,分泌物增多,眼睑肿胀、球结膜水肿。曾使用过各种药物,效果均不佳。使用本发明眼药水3天后,症状消失,没有复发。
5、吕××,女,45岁,工厂工人。患者因外眼睑发炎引发细菌性角膜炎,虹膜变色、瞳孔缩小、结膜水肿,严重影响日常工作与生活。使用本发明眼药水2天后,症状好转,继续使用1天,症状消失,眼睛恢复健康,随访至今未复发。
6、杨××,男,52岁,无业。患者右眼疼痛、流泪、畏光,有视力障碍;结膜水肿,有大量脓性分泌物,被确诊为细菌性角膜炎。使用本发明眼药水1天后,症状明显减轻,继而使用2天,右眼恢复正常,随访至今未复发。
Claims (5)
1.一种治疗细菌性角膜炎的中西复方眼药水,其特征在于:所述眼药水由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:狗狗秧55~85份,吐铁52~82份,骨节草50~80份,蒟酱叶48~78份,当归45~75份,丁葵草40~70份,菥蓂子37~67份,檵花叶35~65份,地柏叶33~63份,苋实30~60份,榕树胶汁28~58份,竹叶蕉26~56份,大巢菜25~55份;制成所述西药成分的原料组成及重量份数为:奥洛他定0.4~1.5份,卡巴胆碱0.3~1.4份,诺氟沙星0.1~1.2份。
2.根据权利要求1所述的一种治疗细菌性角膜炎的中西复方眼药水,其特征在于:所述眼药水由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:狗狗秧78份,吐铁75份,骨节草73份,蒟酱叶71份,当归68份,丁葵草63份,菥蓂子61份,檵花叶59份,地柏叶57份,苋实53份,榕树胶汁51份,竹叶蕉49份,大巢菜48份;制成所述西药成分的原料组成及重量份数为:奥洛他定1.2份,卡巴胆碱1.0份,诺氟沙星0.8份。
3.根据权利要求1所述的一种治疗细菌性角膜炎的中西复方眼药水,其特征在于:所述眼药水由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:狗狗秧71份,吐铁68份,骨节草66份,蒟酱叶64份,当归61份,丁葵草56份,菥蓂子54份,檵花叶51份,地柏叶50份,苋实46份,榕树胶汁44份,竹叶蕉42份,大巢菜41份;制成所述西药成分的原料组成及重量份数为:奥洛他定0.9份,卡巴胆碱0.8份,诺氟沙星0.5份。
4.根据权利要求1所述的一种治疗细菌性角膜炎的中西复方眼药水,其特征在于:所述眼药水由中药和西药成分组成,制成所述中药成分的原料组成及重量份数为:狗狗秧63份,吐铁59份,骨节草58份,蒟酱叶57份,当归53份,丁葵草48份,菥蓂子45份,檵花叶44份,地柏叶39份,苋实38份,榕树胶汁37份,竹叶蕉34份,大巢菜33份;制成所述西药成分的原料组成及重量份
数为:奥洛他定0.6份,卡巴胆碱0.5份,诺氟沙星0.2份。
5.一种如权利要求1~4任一项所述的治疗细菌性角膜炎的中西复方眼药水的制备方法,其特征在于:包括以下工艺步骤:
(1)将狗狗秧、吐铁、菥蓂子和苋实放入容器中,加入相对混合物质量6~8倍量的蒸馏水浸泡2~3天后,加入3~4倍量的质量浓度为45%~55%乙醇,加热回流4小时,过滤,得提取液;将过滤后获得的药渣再加入相对药渣质量4~6倍量的蒸馏水,加热回流2小时;过滤,得提取液和药渣;合并两次提取液,冷却降温至25℃~30℃,过滤,得滤液,备用;
(2)将骨节草、蒟酱叶和大巢菜去除杂质,晒至半干,然后收回堆放,用麻布覆盖,焖两天后,除去麻布并晒至完全干透,捣碎,筛除灰屑,置于研钵内研末,得到过180目的细粉,备用;
(3)将当归和竹叶蕉拣去杂质,大小分档,切片,喷洒3倍量的盐与水的比例为1:50的盐水,搅拌均匀,稍闷润,置锅内用文火微炒至表面略变色,取出晾干,置于研钵内研末,得到过200目的细粉,备用;
(4)将丁葵草、檵花叶和地柏叶洗净,置于榨汁机内榨出汁液,冷藏4小时,过滤,除去杂质与沉淀物,经活性炭吸附进行脱色处理,得滤液,备用;
(5)将奥洛他定、卡巴胆碱和诺氟沙星放入超微粉碎机中粉碎成粒径小于0.1μm体积平均粒径的纳米级颗粒,备用;
(6)将步骤(1)、步骤(4)所得的滤液,步骤(2)、步骤(3)所得的细粉与步骤(5)所得的颗粒混合,加入榕树胶汁与10倍量的蒸馏水,并滴入碳酸氢钠溶液调节PH值至7.0,灌封压盖,在121℃热压下灭菌30分钟,制成10ml/瓶的眼药水,即为所述的治疗细菌性角膜炎的中西复方眼药水。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610703228.6A CN106138502A (zh) | 2016-08-22 | 2016-08-22 | 一种治疗细菌性角膜炎的中西复方眼药水及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610703228.6A CN106138502A (zh) | 2016-08-22 | 2016-08-22 | 一种治疗细菌性角膜炎的中西复方眼药水及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106138502A true CN106138502A (zh) | 2016-11-23 |
Family
ID=57341747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610703228.6A Pending CN106138502A (zh) | 2016-08-22 | 2016-08-22 | 一种治疗细菌性角膜炎的中西复方眼药水及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106138502A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682799A (zh) * | 2004-09-28 | 2005-10-19 | 徐立新 | 一种治疗细菌性、病毒性结角膜炎的眼科外用中药制剂及其制备工艺 |
CN101461777A (zh) * | 2009-01-06 | 2009-06-24 | 河北科技大学 | 一次性使用的不含抑菌剂的盐酸左氧氟沙星滴眼液及其制备方法 |
CN102670494A (zh) * | 2012-05-22 | 2012-09-19 | 宁夏康亚药业有限公司 | 滴眼液及其制备方法与应用 |
-
2016
- 2016-08-22 CN CN201610703228.6A patent/CN106138502A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682799A (zh) * | 2004-09-28 | 2005-10-19 | 徐立新 | 一种治疗细菌性、病毒性结角膜炎的眼科外用中药制剂及其制备工艺 |
CN101461777A (zh) * | 2009-01-06 | 2009-06-24 | 河北科技大学 | 一次性使用的不含抑菌剂的盐酸左氧氟沙星滴眼液及其制备方法 |
CN102670494A (zh) * | 2012-05-22 | 2012-09-19 | 宁夏康亚药业有限公司 | 滴眼液及其制备方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101279027B (zh) | 一种治疗急性结膜炎的中药洗剂制备方法 | |
CN102579918A (zh) | 治疗青光眼的中药组合物、制备方法及给药方式 | |
CN102961521B (zh) | 一种治疗单纯疱疹病毒性角膜炎的药物 | |
CN104096141A (zh) | 一种治疗过敏性结膜炎的中药组合物 | |
CN103877429A (zh) | 一种治疗鼻窦炎的中药制剂及制备方法 | |
CN105125630A (zh) | 一种眼药水及制备方法 | |
CN105168446A (zh) | 一种治疗眼部疾病的中药组合物、眼部美容添加包及其制备方法 | |
CN103505562B (zh) | 用于治疗角膜炎的中药 | |
CN104225339A (zh) | 一种治疗慢性肺炎的中药制剂及制备方法 | |
CN104147516A (zh) | 一种治疗骨髓炎的中药组方 | |
CN104027719B (zh) | 具有治疗感染性心内膜炎引起的脾功能亢进肝郁脾虚型疾病的中药复方组合物及其制备方法 | |
CN103520643B (zh) | 一种用于治疗糖尿病白内障的中药制剂及其制备方法 | |
CN102940753B (zh) | 一种治疗青光眼的药丸及制备方法 | |
CN106138502A (zh) | 一种治疗细菌性角膜炎的中西复方眼药水及制备方法 | |
CN102755549B (zh) | 一种治疗白内障的药物及其制备方法 | |
CN104771470A (zh) | 一种治疗超声乳化白内障吸除术后并发症的药物组合物 | |
CN104983972A (zh) | 一种治疗麦粒肿的滴剂及其制备方法 | |
CN104383152A (zh) | 一种治疗青光眼的中药制剂及制备方法 | |
CN106110009A (zh) | 一种治疗白内障的中药制剂及制备方法 | |
CN104771638A (zh) | 用于治疗视神经萎缩的中药组合物 | |
CN106491730A (zh) | 一种治疗青光眼的中药组合物及其制备方法 | |
CN104524036A (zh) | 一种治疗视神经炎的中药制剂及制备方法 | |
CN104524068A (zh) | 一种治疗红眼病的中药滴眼液及制备方法 | |
CN104958400A (zh) | 一种治疗急性结膜炎的眼膏及其制备方法 | |
CN104971158A (zh) | 一种治疗干眼症的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161123 |
|
RJ01 | Rejection of invention patent application after publication |